- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Aventis Pharmaceuticals
Total 19692 results
-
NovaceaAventis PharmaceuticalsUnknownProstate CancerCanada, United States
-
PfizerAventis PharmaceuticalsTerminatedGram-Positive Bacterial InfectionsUnited States
-
NovaceaAventis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungUnited States
-
Stanford UniversityAventis PharmaceuticalsTerminatedCarcinoma, Non-Small-Cell Lung | Lung CancerUnited States
-
Duke UniversityAventis PharmaceuticalsCompletedOvarian CancerUnited States
-
Stanford UniversityAventis PharmaceuticalsCompletedProstate CancerUnited States
-
Mayo ClinicAventis PharmaceuticalsCompletedRhinitis | Otitis Media With Effusion | Otitis Media, Serous | Negative Middle Ear Pressure | Otitis Media, SecretoryUnited States
-
University of WashingtonAventis PharmaceuticalsCompletedDiabetes Mellitus, Type 1United States
-
University of IowaAventis PharmaceuticalsTerminatedPancreatic CancerUnited States
-
University of MiamiAventis PharmaceuticalsCompletedBreast CancerUnited States
-
Munich Municipal HospitalAventis PharmaceuticalsUnknownCoronary Artery Disease | Type 2 DiabetesGermany
-
University of WashingtonAventis PharmaceuticalsCompletedBreast NeoplasmUnited States
-
Hennepin Healthcare Research InstituteAventis PharmaceuticalsCompletedBrain Injury | Venous ThrombosisUnited States
-
Clinical Oncology Research AssociatesAventis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungUnited States
-
University of California, IrvineAventis PharmaceuticalsCompleted
-
University of Wisconsin, MadisonAventis PharmaceuticalsCompletedOvarian Carcinoma | Primary Peritoneal CarcinomaUnited States
-
University of Southern CaliforniaAventis PharmaceuticalsCompletedProstate AdenocarcinomaUnited States
-
Aventis PharmaceuticalsCompleted
-
Emory UniversitySchering-Plough; Aventis PharmaceuticalsTerminatedSoft Tissue Sarcoma | Breast Cancer | Lung Cancer | Prostate Cancer | Colorectal CarcinomaUnited States
-
SCRI Development Innovations, LLCAventis PharmaceuticalsCompleted
-
SCRI Development Innovations, LLCAventis PharmaceuticalsCompletedProstate CancerUnited States
-
SCRI Development Innovations, LLCAventis PharmaceuticalsCompleted
-
Aventis PharmaceuticalsUnknownHead and Neck CancerUnited States
-
Spanish Lung Cancer GroupAventis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterAventis PharmaceuticalsCompleted
-
Baylor Breast Care CenterAventis PharmaceuticalsCompleted
-
SCRI Development Innovations, LLCAventis PharmaceuticalsCompleted
-
Eli Lilly and CompanyAventis PharmaceuticalsCompleted
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.; Aventis PharmaceuticalsCompleted
-
Jonsson Comprehensive Cancer CenterAventis Pharmaceuticals; GenentecCompletedProstate CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterAventis PharmaceuticalsCompletedLung CancerUnited States
-
SCRI Development Innovations, LLCNovartis; Aventis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterAstraZeneca; Aventis PharmaceuticalsWithdrawn
-
Charite University, Berlin, GermanyPfizer; Aventis PharmaceuticalsUnknown
-
Institut BergoniéNovartis; Aventis Pharmaceuticals; Sanofi-SynthelaboCompleted
-
University of Alabama at BirminghamAventis PharmaceuticalsCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neck NeoplasmsUnited States
-
SCRI Development Innovations, LLCGlaxoSmithKline; Aventis PharmaceuticalsCompleted
-
Royal Marsden NHS Foundation TrustAventis PharmaceuticalsCompletedUpper Gastrointestinal Tumours
-
Assistance Publique - Hôpitaux de ParisAventis PharmaceuticalsCompletedEHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT | CHROMOSOME 2q31.2 DELETION SYNDROME
-
Accelerated Community Oncology Research NetworkAventis PharmaceuticalsCompletedBreast NeoplasmUnited States
-
SCRI Development Innovations, LLCAstraZeneca; Aventis PharmaceuticalsCompletedHead and Neck CancerUnited States
-
West Penn Allegheny Health SystemAventis PharmaceuticalsCompletedGrowth | Allergy | Allergic RhinitisUnited States
-
Institut BergoniéBristol-Myers Squibb; Amgen; Aventis Pharmaceuticals; Sanofi-Synthelabo; Chugai PharmaceuticalCompletedDigestive System Diseases | Lymphoma | Ovarian Diseases | Pulmonary Disease | Bladder Disease | Prostatic DiseaseFrance
-
Gloria VegaRegeneron Pharmaceuticals; Aventis PharmaceuticalsTerminatedNephrotic SyndromeUnited States
-
SCRI Development Innovations, LLCAventis Pharmaceuticals; Sanofi-SynthelaboCompletedEsophagus CancerUnited States
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.; Aventis PharmaceuticalsCompleted
-
University of PittsburghRoche Pharma AG; Aventis PharmaceuticalsTerminated
-
University of PittsburghAventis Pharmaceuticals; Procter and GambleCompleted
-
M.D. Anderson Cancer CenterGenentech, Inc.; Aventis PharmaceuticalsCompletedHead and Neck CancerUnited States
-
SCRI Development Innovations, LLCGlaxoSmithKline; AstraZeneca; Aventis PharmaceuticalsCompletedLung CancerUnited States